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Abstract
Background: The findings of the CAPRISA tenofovir studies have raised expectations that soon an approved
microbicide would be available. However it is in only a limited number of countries in sub-Saharan Africa that the
acceptability of microbicides has been evaluated. We conducted a study to assess the acceptability of vaginal
microbicides among women in rural Ghana.
Methods: The study employs a mixed method design, using cross-sectional survey and focus group discussions to
further understand issues related to awareness and attitudes towards microbicide development, acceptability and
perceived partner attitudes among pregnant women attending antenatal clinic in two health facilities in the
Kintampo North municipality of Ghana. We used logistic regression to identify possible predictors of microbicide
acceptability among the women surveyed.
Results: Although only 2% of the 504 women were aware of the development of microbicides, 95% were willing
to use one when it became available. The cost of a microbicide that will be considered affordable to 50% of
women was US$0.75. Although there were concerns about possible wetting effect, gel or creams were the most
preferred (68% of women) formulation. Although 71% thought their partners will find microbicide acceptable,
apprehensions about the feasibility of and consequences of failed discreet use were evident. 49% of women were
concerned about possible negative effect of microbicide on sexual pleasure. Perceived partner acceptability
(O.R. =17.7; 95%C.I. 5.03-62.5) and possibility of discreet use (O.R. =8.9 95%C.I. 2.63-30.13) were the important
predictors of microbicide acceptability.
Conclusion: Achieving microbicide acceptability among male partners should be made a part of the promotive
interventions for ensuring effective use among women in rural Ghana.
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Background
According to the 2010 UNAIDS report on the global
AIDS epidemic, 33.3 million people live with HIV and
1.8 million deaths due to AIDS occurred in 2009. The
total number of new infections in 2009 was 2.6 million.
Sub-Saharan Africa remains the hardest hit by the HIV/
AIDS pandemic and access to HIV prevention, treat-
ment, care and support in this part of the world remains
a major priority in global health [1,2].
Heterosexual transmission accounts for more than
80% of all new HIV infections in sub-Saharan Africa [3].
Traditional HIV preventive methods such as condom
use, abstinence and “being faithful” are not always feas-
ible due to various socio-economic and cultural factors
[4-6]. Power inequity in relationships and intimate part-
ner violence also increase the risk of HIV infection in
young women [7]. Because of the male-dominated char-
acter of societies in most of sub-Saharan Africa, new and
innovative approaches that empower women in HIV
prevention are needed [8]. Such approaches should how-
ever be carefully evaluated for their acceptability and
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potential for seamless incorporation into national HIV
programs [9].
Microbicides are compounds that can be applied lo-
cally to genital mucosal surfaces to protect against sexu-
ally transmitted infections (STIs) including HIV [10].
They can be formulated as gels, creams, films, or sup-
positories, and may or may not have spermicidal activity
(contraceptive effect). Potential microbicides that have
been investigated to date have been formulated to act
through various mechanisms. This includes acting as
physical barriers to keep HIV and other pathogens from
reaching target cells, maintaining an acidic pH in the va-
gina, enhancing the natural defence mechanisms of the
vaginal mucosa and stripping pathogens of their outer
covering [11,12]. As at the time of writing, the major
focus of HIV research was evaluating how antiretroviral
agents may be used as microbicide. The candidate
microbicide that is in the most advanced stage of devel-
opment is the tenofovir gel [13,14].
After many years of research, characterised by repeated
unfavourable outcomes, the announcement of the findings
of the CAPRISA (Centre for the AIDS Program of Re-
search in South Africa) study in July 2010 represented a
major breakthrough [15]. The study tested the safety and
effectiveness of 1% tenofovir gel among nearly 900 women
at two sites in South Africa. It found that Tenofovir gel
reduced HIV infection by 39%. The VOICE (Vaginal and
Oral Interventions to Control the Epidemic) trial which
was anticipated to strengthen the evidence from the
CAPRISA study, was however discontinued by its Data
Safety Monitoring Board (DSMB). Even though it found
the tenofovir gel safe to use, it did not find it effective in
preventing HIV infection among women in South Africa,
Zimbabwe and Uganda [16]. The FACTS (Follow-on Afri-
can Consortium for Tenofovir Studies) 001 study, a phase
III trial that is testing the same regimen as was used in the
CAPRISA 004 is on-going. There is a considerable expect-
ation that soon an efficacious product will be available
[17]. Modelling studies using data from South Africa sug-
gest that even at low rates of use, the Tenofovir gel could
be highly cost-effective, if it is proven to be an efficacious
microbicide [18-20].
The acceptability of microbicide among the women in a
given population is likely to be a major factor that will de-
termine its effectiveness. In spite of far-reaching develop-
ments towards producing an efficacious microbicide, it is
only in a limited number of settings that its likely accept-
ability has been evaluated. This could be an important
drawback given that issues of human sexuality are often
influenced by a complex interplay of disease, pregnancy
risk perceptions, culture and gender norms regarding sex-
ual practices and relationship dynamics [20,21]. Unless
the acceptability of microbicide is evaluated concurrently
with efforts at developing an efficacious product, its
eventual deployment is likely to be fraught with challenges
that could undermine its effectiveness [21,22].
With a national adult HIV prevalence of 1.5%, Ghana
is among countries in the West African region with gen-
erally low HIV prevalence. There are however some sub-
populations with considerably higher HIV prevalence.
The prevalence of HIV among stationary sex workers,
mobile sex workers and men who have sex with men
have been found to be 52%, 37% and 25% respectively
[23,24]. The patriarchal nature of traditional Ghanaian
society also makes women in rural Ghana particularly
vulnerable to HIV [24]. Preventing new infections is a
major national priority. Ghana is among countries in
sub-Saharan Africa that are likely to rapidly deploy an
effective microbicide once it is approved internationally.
Very little is known about the likely acceptability of
microbicide among women in Ghana [23,25,26].
We conducted a study to assess microbicide accept-
ability among rural women in Ghana. Our objective is to
contribute to the smooth incorporation of microbicides
use in HIV prevention programs in the country once an
efficacious product is approved.
Methods
Study setting
The study was undertaken in Kintampo, the municipal
capital of the Kintampo North municipality of the Brong
Ahafo Region of Ghana. This municipality lies at the exact
geographical mid-point of Ghana and covers a land area
of 5108 square kilometres. Most of the municipality is
rural, with subsistence farming being the major occupa-
tion of the 96,358 inhabitants. A substantial proportion of
the population are either migrant from the northern parts
of the country or government workers who have been
posted from the south. The strategic importance of Kin-
tampo derives from the fact that it is a major stopover for
passengers and haulage trucks plying the transnational
highway between Ghana’s seaports in the south and its
northern belts, including landlocked countries such as
Burkina Faso, Mali and Niger. The Kintampo Lorry Park
remains a beehive of commercial activity; day and night,
seven days in the week. Anecdotal evidence suggests that
commercial sex work thrives well in Kintampo.
Study population
Study subjects were women who were aged between 18
and 40 years who were resident in either Kintampo or
adjoining small towns and villages. The procedures for data
collection consisted of both quantitative (questionnaire sur-
vey) and qualitative (focus group discussions) approaches.
Quantitative approach
A questionnaire survey was conducted among pregnant
women who were attending routine antenatal clinics in
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two health facilities in the Kintampo municipality over
a 2-month period in 2010. The facilities are the Kin-
tampo Municipal Hospital, which is a public health fa-
cility, and the Prince of Peace maternity home, which is
a private health facility. All women aged 18–40 years
were targeted to be interviewed. The questionnaire
explored the socio-demographic background of respon-
dents and their partners, their awareness and attitude
towards the development of microbicides, their accept-
ability and perceived acceptability of their partners. Ma-
jority of the questions were closed-ended. The
questionnaire was finalised after pre-testing at the same
facilities in the week prior to the conduct of the actual
study. They were administered verbally by research
assistants who were trained to explain microbicides in
the context of heterosexual contact, how it will be ap-
plied and the anticipated benefit of protecting against
HIV infection. Research assistants explained microbi-
cides as: “Compounds that can be applied inside the va-
gina to protect against Sexually Transmitted Diseases
(STDs) including HIV”.
Data from the survey was double-entered, verified and
cleaned using Microsoft Access. Analysis was done
using STATA version 10. Analysis was performed to de-
scribe the socio-demographic background of respon-
dents, proportion of respondents accepting to use
microbicide and the preference for various formulations
and other attributes. Univariate and multivariate ana-
lysis using logistic regression were performed to deter-
mine the factors associated with the acceptance of
microbicide. Statistical significance was accepted when
P-value was less than 0.05.
We targeted to interview 500 pregnant women and
expected that this sample will afford the estimation of
the level of acceptance of microbicides with a margin of
error of 4% (at 95% confidence level), assuming that
microbicides was acceptable to 50% of respondents.
Qualitative approach
The preliminary findings of the survey were used to gen-
erate thematic areas that were explored further using
focus group discussions (FGDs). Three FGDs were con-
ducted with women aged 18–40 years living within the
Kintampo municipality. Discussion groups were made of
8–12 people of about the same age. With age as a guid-
ing criteria, women were classified into three categories;
18–25, 26–32, 33–40 years. The discussions were facili-
tated by a note taker and a moderator who used a guide
developed from preliminary analysis of the quantitative
survey, and related issues in the literature. All discus-
sions were conducted in the local dialect and tape-
recorded. They were then transcribed, translated from
the local language into English and typed. The tran-
scripts were read and responses grouped according to
the thematic areas generated from the survey. Additional
themes were added to the coding framework as deter-
mined by the data. The qualitative data was reviewed by
two persons. To ensure inter-coder agreement and reli-
ability 10% of the transcripts were coded independently
and this was followed by a debriefing sessions to discuss
the level of consensuses. Inter-coder reliability was al-
ways above 90%. A framework approach was adopted in
the analysis which was performed using the software,
QSR Nvivo (version 8).
Ethical consideration
Ethical approval for the conduct of the study was obtained
from the Institutional Ethics Committee of the Kintampo
Health Research Centre. Administrative approval was also
obtained from authorities of the two facilities where the
study was conducted. Written Informed consent was
sought from each respondent. Women were informed that
they were free to decline to participate or withdraw. They
were also assured of the confidentiality of the information
they provide.
Results
The findings of the survey and the focus group discus-
sions were triangulated and are reported here with per-
centages that refer to findings from the survey and
quotations that have been extracted from the FGDs.
A total of 504 women were surveyed. Their mean age
was 26.0 years (stdev. 5.9). While 37% of women had
had no formal education, 5.0% had had education be-
yond senior high school. Most of the women were
Christians (71%) and petty traders (40%). Over half
(59%) of them were married. About a third (34%) had no
children, while 26% had only one child. The majority
(55%) of them lived within the Kintampo Township.
Only 11% of women lived outside of the Kintampo mu-
nicipal. In univariate analysis, the acceptability of micro-
bicide was found to be influenced by perceived partner
acceptability (O.R. =11.5, 95% C.I. 3.65-36.24), perceived
feasibility of discreet use (O.R. =9.77, 3.78-25.27), reli-
gion (O.R. =2.67, 1.16-6.12), age of partner (O.R. =0.31,
0.13-0.78) and whether the partner had children beside
those with the woman interviewed (O.R. =0.42, 0.18-
0.96) (Table 1). In multivariate analysis however only
perceived partner acceptability (O.R. =17.7, 5.03-62.5)
and perceived feasibility of discreet use (O.R. =8.9, 2.63-
30.13) emerged as significant independent predictors of
microbicide acceptability.
Awareness
Only 2% of women were aware of the development of
vaginal microbicide. In terms of familiarity with surro-
gates, 37% of women had had experience with the use of
spermicides, 19% with lubricant use during sexual
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Table 1 Univariate analysis of the association between various factors and the acceptability of vaginal microbicides
Characteristics Acceptability 0R (95% C.I.) P-value
Yes No
Socio-demographic characteristics of respondents
Age (yrs) >=26 202 14 0.52 (0.23-1.20) 0.12
<26 278 10
Highest educational level Beyond primary 232 8 1.87 (0.78-4.47) 0.15
Primary 248 16
Ethnicity Non-Akan 312 18 0.62 (0.24-1.60) 0.32
Akan 168 6
Religion Christian 344 12 2.67 (1.16-6.12) 0.02
Muslim 129 12
Occupation Skilled 61 1 4.56 (0.59-35.13) 0.11
Non-skilled 254 19
No of children At least one 315 19 0.50 (0.18-1.37) 0.71
None 165 5
Place of residence Outside of town 163 11 0.61 (0.26-1.45) 0.26
Kintampo town 266 11
Socio-demographic characteristics of partner
Age (yrs) >=34 207 17 0.31 (0.13-0.78) 0.01
<34 272 7
Highest educational level Beyond primary 296 12 1.61 (0.71-3.66) 0.25
Primary 184 12
Ethnicity Non-Akan 340 19 0.64 (0.23-1.75) 0.38
Akan 140 5
Religion Christian 315 11 2.60 (1.11-6.08) 0.02
Muslim 132 12
Occupation Skilled 105 4 1.63 (0.54-5.00) 0.38
Non-skilled 289 18
Issues of marital relationship
Years of marriage >=5 252 13 0.94 (0.41-2.13) 0.87
<5 228 11
Nature of marriage Traditional rites 195 11 1.97 (0.78-4.96) 0.14
Church rites 81 9
Stay in same house Yes 327 19 0.56 (0.21-1.54) 0.26
No 153 5
Has children with other women Yes 109 10 0.42 (0.18-0.96) 0.03
No 370 14
Previously married Yes 49 5 0.43 (0.15-1.22) 0.10
No 429 19
Has other wife(s) Yes 54 3 1.13 (0.32-3.91) 0.85
No 426 21
Likely attitude towards microbicides
Partner will find acceptable Yes 351 5 11.51 (3.65-36.24) <0.01
No 61 10
Ability to use secretly Yes 389 7 9.77 (3.78-25.27) <0.01
No 91 16
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intercourse and 7% with other substances inserted into
the vagina to enhance sexual pleasure.
Comparison with other products
During the FGDs, many women likened the action of
microbicide to how contraceptives and lubricants
worked to prevent pregnancy and to enhance sexual
pleasure respectively. Women who found it difficult to
appreciate the mechanism of action of microbicides used
contraceptive methods, sexual lubricants and fungicidal
suppositories as reference materials. Such misconcep-
tions were typically put as follows
“The way you have explained it, if a woman wants
contraceptive protection, she should go for it. So yes,
we can use it”
“..You know sometimes you as a woman is tired of child
bearing, but the man wants more children. When this
happened you will be able to hide and use it”
“Sometimes some people sell some drugs that people
buy and insert for the men to enjoy sex with them”
“I know of a foaming tablet that can last for an hour. I
don’t know if that is what you are talking about”
“I have used something like that before. It is like a
seed. I had to insert it. It was for treating white
(candidiasis)”
Only 1% of women indicated there were taboos in
their cultures against the insertion of fingers into the va-
gina. Further enquiry during the FGDs did not yield
new information on the existence of such taboos in the
local culture. However a few women had difficulty re-
conciling the approach to using a microbicide with the
health advice against douching. Some illustrative quotes
are:
“What I know is that some nurses will tell you not to
insert your fingers in the vagina; even washing the
area is not advised since they say the vagina has a
natural way of cleaning itself”
“I have not heard anything like that but it is more like
putting drugs there that is not encouraged”
Formulation preferences
Gel or creams were the most preferred (68% of women)
microbicide formulation. In the FGDs however, concerns
were expressed about the wetting effect of gels and
creams, and how microbicides could affect sexual pleas-
ure. For these reasons, some women wished that
microbicides were tablets that could be swallowed. Such
views were typically put as follows:
“I will like it in the form of a tablet to be swallowed
because using a cream on a vagina will make the
place wet, uncomfortable or some way”
“It should be a tablet to be swallowed because in the
vagina it will melt and make the vagina soggy”
“....it is important that the vagina is tight. It makes
you enjoy the sex better”
Compared to non-perfumed, red cream-coloured
microbicide, fifty eight (58%) of respondents preferred
perfumed and white microbicide.
Acceptability
The overwhelming majority (95%) of women indicated
they will be willing to use a microbicide if it became
available. This extent of overwhelming acceptability was
confirmed during the FGDs; typically put:
“Even if it becomes available this month we will really
be happy”
Places where women felt they will be comfortable to
receive free microbicides were health-related facilities
(89-97% of women) such as chemical shops and hospi-
tals, cosmetic shops (39%) and supermarkets (26%). The
majority of women considered food vending spots as the
least comfortable places to obtain free microbicides. For
use in one round of sexual intercourse, the cost of a
microbicide that will be considered affordable was US
$0.75 by 49% of women and $1.50 by 15%. Majority (66%)
of women would prefer to get microbicides from female
vendors. Nearly all (99%) of the respondents preferred that
such vendors be either of the same age (48%) or older
(51%), and be persons they were not socially familiar with.
Convert use
About 71% of women thought that their partners will
find their use of microbicide acceptable, while 21%
thought they would not be able to use it discreetly with-
out their partners becoming aware. Apprehension about
the feasibility and consequences of discreet use was ap-
parent in the contribution of most women in the FGDs.
“For some men they will never agree for you to use it.
If it were pills you could use it without his knowledge”
“If its pills you can use it secretly”
“No I cannot hide it from him”
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Beside the effect of preventing HIV infection, 49% of
women were concerned about the possible effect of
microbicide on sexual pleasure. A quote by one woman
in a focus group discussion illustrates this:
“Sexual pleasure is very important to men, you know
some men have sex with some women and they say
they enjoyed because her vagina is tight and the other
way round. So prevention is important but sexual
pleasure is paramount.”
Discussion
Until recently the appropriateness of research on micro-
bicide acceptability was questioned on the basis of the
absence of an approved product [21,27,28]. However the
need for such research among a wider population of po-
tential end-users has now become urgent because of the
significant progress that has been made in the develop-
ment of an efficacious product. Such research is essential
for generating useful information about potential user
preferences including product characteristics such as
formulation, colour, odour, feel, ease of use and impact
on sexual pleasure. These attributes need to form an im-
portant part of microbicide development and the strat-
egies for its promotion [21,23,29].
In the absence of a marketed product and away from a
microbicide trial setting, the form of microbicide accept-
ability evaluated in our study could be described as per-
ceived acceptability, i.e. satisfaction with the product and
willingness to use it in the future or recommend it to
others [21]. In this regard, the perception of respondents
is based on their understanding of the product as
explained by the investigators and on the basis of experi-
ence with microbicide-like products. It is conceivable
that perceptions could change after experience with real
products when they become available.
Our finding of a possible association between religious
persuasion and microbicide acceptability coincides with
the findings of Hoel N et al. 2011, who conducted a
qualitative study to assess the reflections of Muslim
women on the acceptability of vaginal microbicidal pro-
ducts in South Africa [30]. Although we failed to explore
this further in the FGDs, we believe that it should
prompt attention to the possibility that religious sensitiv-
ities could impact on the acceptability of microbicide
among some sections of the society.
One of the important justifications that continue to
drive interest in microbicides development is the consid-
eration that it is a female-initiated product which can be
used covertly. In many settings in sub-Saharan Africa,
women are vulnerable to the possibility of partner vio-
lence, relationship termination, with attendant loss of fi-
nancial support and social status [30]. As the findings of
our study suggest covert use is likely to fester mistrust
particularly when the male partner gets to find out. Lim-
ited education, limited employment opportunities and
low income even if employed, force many women in
sub-Saharan Africa to have men in their lives to ensure
their survival [31]. Thus most women in this part of the
world are not socially well-placed to take such “risk”
[32]. Our finding that microbicide acceptability was
strongly associated with perceived male partner accept-
ability is therefore not entirely unexpected. While many
women may wish that it were possible to use a microbi-
cide covertly, it does not appear that they consider it to
be feasible. Among women who were reported to find
microbicide acceptable in three sites in Africa and India,
concerns about covert use were tied to issues of partner
acceptability and preference, wetting effect, faithfulness
and questionable health status [33]. Again, several stud-
ies have documented fear of abuse and other serious
consequences especially in patriarchal societies where
women generally have low assertive skills to negotiate
safe sex [33-35]. The message of discreet use is therefore
unlikely to be socially acceptable to women in formal
and relatively stable relationships. It is unlikely to be a
convincing enough message to rely upon in the promo-
tion of microbicides. There is evidence to suggest that
women would actually wish to be able to tell their part-
ners and have their support [36-38]. In a study in
Uganda that was linked to a microbicide trial, it was
reported that whereas women during the pre-trial period
believed that surreptitious microbicide use was advanta-
geous, after the first week of product use, only 40% had
actually been able to use the product secretly, 27% after
5 weeks, 22% after 10 weeks, and 13% after 5 months
[38]. In other similar studies, even though women found
microbicide gel highly acceptable, consistent use was
tied to partner related factors which emphasises the
need to adequately address partners acceptance in
microbicide promotion [33,39].
In the promotion of microbicides, messages that
promote its advantages for male partners need to be
highlighted. An example is the reduced infectivity of
HIV-infected women during heterosexual contact. For
uninfected male partners, the use of microbicides should
be promoted as being mutually beneficial in reducing,
the risk of HIV infection for both male and female part-
ners. Consistent microbicides should be promoted as
the best available alternative for male partners who are
reluctant to use condoms.
Sexual pleasure has emerged as an important consider-
ation related to microbicide acceptability [40,41]. The
values that societies place on sex vary across different cul-
tural settings. In many cultures in sub-Saharan Africa, a
norm has been established that females have the greater
responsibility to satisfy the sexual pleasures of their part-
ners [32,39]. This burden is considered greater when the
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woman finds herself in a polygamous marriage or when
she has cause to believe that the male partner has other
partners. It would appear unreasonable to ask a woman to
use a product that could undermine her ability to satisfy
her male partner sexually. In a study in Africa and India,
acceptability of microbicide gel among women was linked
to its lubricating effect and its consequent effect on sexual
pleasure [33]. Several microbicide studies have reported
how gender power affects the balance between the desire
for sexual pleasure and acceptability of microbicide
[34,39,42]. Our finding that nearly half of the women were
concerned about the effect of microbicides on sexual
pleasure is therefore not entirely unexpected. It corrobo-
rates similar reports from other studies, including those
conducted outside sub-Saharan Africa [43]. In one of the
failed microbicides trials, women were reluctant to return
unused gel which had been given to them, even in the
context of possible harm; because they reported that it
made sex more pleasurable [29]. Any microbicide that ad-
versely affects sexual pleasure is unlikely to be found ac-
ceptable, regardless of its efficacy. On the other hand, an
efficacious product that has the added property of enhan-
cing sexual pleasure is likely to be considered acceptable
and more likely to be used consistently. Achieving a for-
mulation that has the right biophysical and rheological
properties to guarantee efficacy and sustain sexual pleas-
ure should therefore remain a twin goal in microbicides
development.
Study limitations
A hypothetical microbicide was described to respon-
dents in the study, most of whom were unfamiliar with
the use of microbicides. In addition, some respondents
may have considered some of the questions posed to be
culturally sensitive. In spite of training to ensure uni-
formity, it is conceivable that respondents may have
been influenced by the way the interviewers described
the action of microbicides, and or how they posed the
questions.
All the respondents in the study were women living in
rural areas in Ghana. It is possible that women living in
urban areas could have different perceptions of microbi-
cides. The study was carried out in the wake of the re-
lease of the results of the CAPRISA 004 trial. The field
of microbicide development is however evolving rapidly
and as yet no microbicide has been approved by the
World Health Organisation. Contradictory results have
also emerged in other trials.
Conclusion
The eventual availability of an approved microbicides is
likely to be welcome news to rural women in Ghana. Be-
lying such enthusiasm however are contextual issues
such as religious persuasion, effect on sexual pleasure
and perceived partner attitude. Unless such issues are
addressed in product development and promotion, ap-
parently high levels of microbicide acceptability are un-
likely to be matched by consistent use.
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